Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Advocates often emphasize the possibility for substantial therapeutic benefits, especially in diseases where conventional therapies have proven inadequate. However, crucially important to consider the significant financial burden associated with CPI s